INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD sold 0.0% of their position (10.00 shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $137.30 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/18/2026ACC: 0001140361-26-028846
→
10% Owner
Since Jun 2026
-10.00
Net shares
Net seller
$137.30
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10.00
Price / share
$13.73
Trade value
$137.30
% of position
0.0%
7/16/2026
2.86M→2.86M
Total
Net shares
−10.00
Net value
-$137.30
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/16/2026 | S · Sale | −10.00 | $13.73 | $137.30 | 0.0% | 2.86M | 2.86M |
| Total | −10.00 | -$137.30 | ||||||
Derivative Transactions0
No derivative transactions reported